Type 1 diabetes trials in Argentina

1 of 6 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin

  Where

  Buenos Aires

  Age

  18 years and over

  People

  145

  Run by

  Hospital Italiano de Buenos Aires

  See details and how to joinNCT07621419